Natamycin 7681-93-8
| Systematic (IUPAC) name: |
(1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(3-amino-3,6-dideoxy-D-mannopyranosyl)oxy]-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid |
| Natamycin CAS number: |
7681-93-8 |
| ATC code: |
A01AB10 A07AA03,D01AA02,G01AA02,S01AA10 |
| PubChem: |
441382 |
| DrugBank: |
APRD01136 |
| Formula: |
C33H47N1O13 |
| Molecular mass: |
665.725 g/mol |
| Natamycin Assay/Purity: |
Typically NLT 98% |
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.
